Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors
- PMID: 38782906
- PMCID: PMC11116398
- DOI: 10.1038/s41467-024-48685-4
Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors
Abstract
The parasite Toxoplasma gondii persists in its hosts by converting from replicating tachyzoites to latent bradyzoites housed in tissue cysts. The molecular mechanisms that mediate T. gondii differentiation remain poorly understood. Through a mutagenesis screen, we identified translation initiation factor eIF1.2 as a critical factor for T. gondii differentiation. A F97L mutation in eIF1.2 or the genetic ablation of eIF1.2 (∆eif1.2) markedly impeded bradyzoite cyst formation in vitro and in vivo. We demonstrated, at single-molecule level, that the eIF1.2 F97L mutation impacts the scanning process of the ribosome preinitiation complex on a model mRNA. RNA sequencing and ribosome profiling experiments unveiled that ∆eif1.2 parasites are defective in upregulating bradyzoite induction factors BFD1 and BFD2 during stress-induced differentiation. Forced expression of BFD1 or BFD2 significantly restored differentiation in ∆eif1.2 parasites. Together, our findings suggest that eIF1.2 functions by regulating the translation of key differentiation factors necessary to establish chronic toxoplasmosis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Update of
-
Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors.bioRxiv [Preprint]. 2024 May 15:2023.11.03.565545. doi: 10.1101/2023.11.03.565545. bioRxiv. 2024. Update in: Nat Commun. 2024 May 23;15(1):4385. doi: 10.1038/s41467-024-48685-4. PMID: 37961607 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- R21 AI167662/AI/NIAID NIH HHS/United States
- R01 AI158501/AI/NIAID NIH HHS/United States
- R21 AI160610/AI/NIAID NIH HHS/United States
- R01 AI172752/AI/NIAID NIH HHS/United States
- R01 AI120607/AI/NIAID NIH HHS/United States
- F30AI169762/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01AI120607/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- P30 CA046592/CA/NCI NIH HHS/United States
- R01GM138939/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01AI172752/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R00 GM111858/GM/NIGMS NIH HHS/United States
- R01AI158501/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R00GM111858/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R21AI167662/U.S. Department of Health and Human Services (U.S. Department of Health & Human Services)
- R21AI160610/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- F30 AI169762/AI/NIAID NIH HHS/United States
- T32 GM007863/GM/NIGMS NIH HHS/United States
- R01 GM138939/GM/NIGMS NIH HHS/United States